<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08800065900251</udiDi>
    <basicUdiDi>B-08800065900251</basicUdiDi>
    <tradeName>08800065900251</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT fine</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:45.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900244</udiDi>
    <basicUdiDi>B-08800065900244</basicUdiDi>
    <tradeName>08800065900244</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT Sub-Q</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:43.963Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900237</udiDi>
    <basicUdiDi>B-08800065900237</basicUdiDi>
    <tradeName>08800065900237</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:42.746Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900220</udiDi>
    <basicUdiDi>B-08800065900220</basicUdiDi>
    <tradeName>08800065900220</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Light</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:41.654Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900213</udiDi>
    <basicUdiDi>B-08800065900213</basicUdiDi>
    <tradeName>08800065900213</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Ultra</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:34.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900206</udiDi>
    <basicUdiDi>B-08800065900206</basicUdiDi>
    <tradeName>08800065900206</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Deep Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:33.126Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900190</udiDi>
    <basicUdiDi>B-08800065900190</basicUdiDi>
    <tradeName>08800065900190</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Light Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:31.923Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900183</udiDi>
    <basicUdiDi>B-08800065900183</basicUdiDi>
    <tradeName>08800065900183</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Ultra Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:30.826Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342143</udiDi>
    <basicUdiDi>B-08684771342143</basicUdiDi>
    <tradeName>FILLENSE</tradeName>
    <deviceName>FILLENSE Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF139</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:37.544Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342136</udiDi>
    <basicUdiDi>B-08684771342136</basicUdiDi>
    <tradeName>FILLENSE</tradeName>
    <deviceName>FILLENSE Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF107</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:35.126Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342129</udiDi>
    <basicUdiDi>B-08684771342129</basicUdiDi>
    <tradeName>FILLENSE</tradeName>
    <deviceName>FILLENSE Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF104</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:33.935Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342112</udiDi>
    <basicUdiDi>B-08684771342112</basicUdiDi>
    <tradeName>FILLENSE</tradeName>
    <deviceName>FILLENSE Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF101</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:30.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342105</udiDi>
    <basicUdiDi>B-08684771342105</basicUdiDi>
    <tradeName>PHASELISS Filler</tradeName>
    <deviceName>PHASELISS Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF139</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:26.724Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342082</udiDi>
    <basicUdiDi>B-08684771342082</basicUdiDi>
    <tradeName>SEMICAL Filler</tradeName>
    <deviceName>SEMICAL Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF106</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:24.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342044</udiDi>
    <basicUdiDi>B-08684771342044</basicUdiDi>
    <tradeName>SEMICAL Filler</tradeName>
    <deviceName>SEMICAL Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF139</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:23.139Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342037</udiDi>
    <basicUdiDi>B-08684771342037</basicUdiDi>
    <tradeName>SEMICAL Filler</tradeName>
    <deviceName>SEMICAL Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF107</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:20.773Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342020</udiDi>
    <basicUdiDi>B-08684771342020</basicUdiDi>
    <tradeName>SEMICAL Filler</tradeName>
    <deviceName>SEMICAL Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF104</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:17.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>08684771342013</udiDi>
    <basicUdiDi>B-08684771342013</basicUdiDi>
    <tradeName>SEMICAL Filler</tradeName>
    <deviceName>SEMICAL Filler</deviceName>
    <manufacturerName>Semikal Teknoloji San. ve Tic. A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000024212</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DF101</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-30T20:32:14.713Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993074310</udiDi>
    <basicUdiDi>17649993074KYS4UJZ</basicUdiDi>
    <tradeName>Kysense Extreme</tradeName>
    <deviceName>Kysense Precise</deviceName>
    <manufacturerName>Kylane Laboratoires</manufacturerName>
    <manufacturerSrn>CH-PR-000032104</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>KYS-A310-4U</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:10.830Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993074303</udiDi>
    <basicUdiDi>17649993074KYS4UJZ</basicUdiDi>
    <tradeName>Kysense Volume</tradeName>
    <deviceName>Kysense Precise</deviceName>
    <manufacturerName>Kylane Laboratoires</manufacturerName>
    <manufacturerSrn>CH-PR-000032104</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>KYS-A210-4U</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:04.834Z</lastUpdated>
  </row>
</eudamedExport>